Article

Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension

2020-09-09

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>Headache is the dominant factor for quality of life related disability in idiopathic intracranial hypertension (IIH) and typically has migraine-like characteristics. There are currently no evidence-based therapeutics for headache in IIH, and consequently this is an important unmet clinical need.<bold>Case series</bold>We report a series of seven patients in whom h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 801047fd-a235-5e61-a7d6-5c8d2285ed2a
DOI: 10.21203/rs.3.rs-40270/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertensionDOI 10.21203/rs.3.rs-40270/v2Read

Plasma Calcitonin Gene-Related Peptide Levels in Idiopathic Intracranial Hypertension: An Exploratory StudySemantic proximity Read

Erenumab in highly therapy-refractory migraine patients First German Real-world evidenceSemantic proximity Read

Intracranial Pressure Directly Predicts Headache Morbidity in Idiopathic Intracranial HypertensionSemantic proximity Read

Galcanezumab Add-on in Refractory Cluster HeadacheSemantic proximity Read

Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomeSemantic proximity Read

Safety efficacy and tolerability of the calcitonin gene-related peptide monoclonal antibodies for migraine prevention in a real world settingSemantic proximity Read

Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity Read

Real-world Evidence Data on the Monoclonal Antibody Erenumab in Migraine Prevention: Perspectives of Treating Physicians in GermanySemantic proximity Read

Cluster headache: new targets and options for treatmentSemantic proximity Read

Treatment of Persistent Post-Traumatic Headache with the Anti-CGRP Receptor Antibody Erenumab: A Case ReportSemantic proximity Read

Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity Read

Idiopathic intracranial hypertension carries a high medication overuse headache burden and a chronic-headache-like opioid related disorder risk: a nationwide cohort studySemantic proximity Read